GlassScriptPhysician profile
Thomas J Wilkins
NPI 1043231756
$3,069.06
in general payments reported to CMS, 2019-2025
16 companies · $725 in 2025
The $725 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $83.34 · 2021: $32.07 · 2022: $643 · 2023: $617 · 2024: $588 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,929.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,190.28 | 2022-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $634.16 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $389.88 | 2019-2025 | Belbuca, Xtampza |
| Avanos Medical | $171.57 | 2019-2021 | |
| Medtronic, INC. | $170.81 | 2023-2025 | Synchromedii, Kyphon Express II Kyphopak Tray, Accurian |
| Si-Bone, INC. | $137.60 | 2024 | |
| Allergan, INC. | $105.85 | 2019-2020 | |
| Pfizer INC. | $47.32 | 2019-2020 | |
| Curonix LLC | $40.49 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Scilex Pharmaceuticals INC. | $31.41 | 2019 | |
| Biodelivery Sciences International, INC. | $30.94 | 2019 | |
| Pacira Therapeutics, INC. | $30.31 | 2019-2020 | |
| Tersera Therapeutics LLC | $26.47 | 2025 | Prialt |
| Daiichi Sankyo INC. | $24.61 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.21 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $15.15 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wilkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.